JPRN-UMIN000025112尚未招募未知
Clinical efficacy of Liquid biopsy for acquired resistance to afatinib in EGFR positive NSCLC - Liquid biopsy for acquired resistance to afatinib
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Investigation on the usefulness of liquid biopsy for tumor-derived circulating DNA in patients with EGFR-mutant NSCLC during and after treatment with EGFR-TKIson-small cell Lung CancerJPRN-UMIN000023248PHRF122
进行中（未招募）
1 期
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code: 10025055Term: Lung cancer non-small cell stage IV Class: 10029104CTIS2024-511317-38-00Fundacion GECP33
进行中（未招募）
1 期
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864EUCTR2019-002369-36-ESFundación GECP30
招募中
不适用
Research on Liquid Biopsy in Patients with Gastrointestinal and Abdominal Malignancies, Including Colorectal Cancernresectable advanced or reccurrent gastrointestinal malignanciesJPRN-UMIN000029315ational Cancer Center Hospital East7,000
招募中
不适用
Exploratory research of liquid biopsy for patients with cancercancerJPRN-UMIN000033269Cancer Precision Medicine Center Cancer Institute,800